Neocis customer adoption for Yomi grows rapidly with thousands of dental implant surgeries already performed in 47 cities across the U.S.
by neocis
When it comes to cutting-edge tech in dentistry, it’s all about nanotechnology. Shannon Sommers and Alicia Webb explain the basics and what these exciting new developments could mean for your practice.
Before the patient is in the dentist’s chair, Dr. Ryaz Ansari and his surgical assistant discuss the angle, depth and positioning of the dental implant they’re about to place. Using a robotic device called the “Yomi,” the surgical assistant moves the virtual dental implant with a mouse, as Ansari looks at the computer screen, which displays a 3D image of the patient’s jaw. Observing the digital dental implant’s position in the jaw on the screen, Ansari, an oral and maxillofacial surgeon who practices at JawFixers in West Hartford and Manchester, says, “I want it a little more inwards. That’s good. If you can just rotate this up. … Let’s bring that line to the middle. Excellent. Beautiful.”
When placing a titanium dental implant, the oral surgeon has to think about placing it deep enough and at the right angle without it touching the nerves or the sinuses, which are millimeters away. Before calling the waiting patient in, Ansari and the assistant double-check each measurement again.
MIAMI, Fla., USA: Neocis, a supplier of robot-assisted dental implant surgery, has announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a new Yomi edentulous indication.
According to Neocis, the clearance allows for a new splint attachment that broadens Yomi’s application to include full-arch implant cases as well as partially edentulous cases. The American College of Prosthodontists estimates that more than 36 million Americans are missing all their teeth. The new Yomi edentulous splint will enable doctors to use Yomi’s technology to reach more of this population, Neocis said.
“I am delighted today to report that we have received 510(k) clearance for Yomi to assist with full arch implant surgeries. With this clearance, Yomi doctors will be able to leverage robotic technology to treat more patients and restore more smiles,” said Alon Mozes, PhD, CEO of Neocis.
Neocis, Inc., the leader and pioneer in robot-assisted dental implant surgery, announced today that they have received 510(k) clearance from the US Food and Drug Administration (FDA) for a new Yomi® edentulous indication. The clearance allows for a new splint attachment which broadens Yomi’s application to include full arch implant cases as well as partially edentulous cases. The American College of Prosthodontists estimates that over 36 million Americans are missing all their teeth. The new Yomi edentulous splint will enable doctors to use Yomi’s technology to reach more of this population.
“I am delighted today to report that we have received 510(k) clearance for Yomi to assist with full arch implant surgeries. With this clearance, Yomi doctors will be able to leverage robotic technology to treat more patients and restore more smiles,” said Alon Mozes, PhD, Chief Executive Officer of Neocis.
MassDevice, recognized throughout the med-tech industry as a go-to source for originally-reported, quality news coverage, reported that Neocis announced filing for FDA 510(k) clearance for its Yomi edentulous splint to aid its dental robotic surgical system.
According to Mass Device reporter , “the Miami-based company’s new splint is designed to enable the Yomi dental robotic system to go beyond placing implants for partially edentulous patients, with new capabilities for assisting doctors with full arch implant cases, according to a news release. The edentulous splint is set to help restore the dentition and smiles of people who are missing their teeth.”
Read more: https://www.massdevice.com/neocis-seeks-510k-nod-for-yomi-edentulous-splint-for-robotic-dental-surgery/